Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Unilever N.V. (ADR) (UN), The Procter & Gamble Company (PG), Colgate-Palmolive Company (CL): Consumer Goods Companies, Great Expectations

Page 1 of 2

There has been a major shift in the consumer goods industry. Consumer spending in developed markets is hesitant to pick up as is still held back by a sluggish economy and high unemployment. This macro-economic environment, however, has been beneficial for developing countries, where sales have been growing at a fast pace along with optimal branding and positioning.

This industry is governed by big global companies that own a wide portfolio of brands in a variety of categories. If you are planning on adding some consumer goods producers to your portfolio you should take a close look at these three big firms.

Emerging Markets are keeping the growth going

Unilever N.V. (ADR) (NYSE:UN) supplies personal & home care products, food and refreshments on a global scale.

Unilever N.V. (ADR) (NYSE:UN)

The company showed very good results for its first quarter. Underlying sales rose 4.9% driven by a 2.2% volume increase and a 2.6% gain in prices. The best performance was shown by emerging markets, with a 10.4% year over year growth in underlying sales.

Unilever N.V. (ADR) (NYSE:UN) is characterized by its increasing investments in innovation and improved product quality. The firm is continuously introducing its brands in new markets, which contributes to its growth. Management’s main focus is on emerging markets, which are showing double-digit growth for Unilever N.V. (ADR) (NYSE:UN) while sales remain flat in the developed markets. In order to optimize resources in these promising markets, the firm is focusing on divesting its non-core operations. In Aug. 2012 Unilever sold its frozen foods business to ConAgra Foods, Inc. (NYSE:CAG) and more recently its Skippy peanut butter brand to Hormel Foods Corporation (NYSE:HRL).

I am optimistic about the company’s wide brand portfolio since it guarantees a strong presence and dominant market share. This goes along with Unilever N.V. (ADR) (NYSE:UN)’s acquisition strategy, which recently involved buying Sara Lee and Alberto Culver to strengthen its personal care business in Western Europe and hair products in the U.S. respectively.

The main threats to the company are macro economic challenges, which I expect will persist throughout 2013.

Former CEO coming back to ameliorate performance

The Procter & Gamble Company (NYSE:PG) provides consumer packaged goods in more than 180 countries.

The company reported mixed results for its third quarter. Earnings improved 5% year over year, driven by strong cost savings and lower taxes. However, sales lagged due to slower market performance and weak beauty sales. Management expects fourth-quarter sales to decline compared to the same quarter of 2012 which indicates some concerns. Fiscal 2012 was a tough year for The Procter & Gamble Company (NYSE:PG): So tough that the company just announced the reappointment of its former CEO, A.G. Lafley, replacing his own replacement, Bob McDonald.

We have to acknowledge that The Procter & Gamble Company (NYSE:PG) is an emerging market company and this is where its main efforts should be addressed. Bob McDonald could not manage to successfully execute the company’s strategy in these markets and well, time was up.

Page 1 of 2

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!